Results 151 to 160 of about 12,992 (201)

Research Progress in Pharmacological Targeted Therapy for Myasthenia Gravis. [PDF]

J Inflamm Res
Zhou Y, Wu Y, Meng Z.
europepmc   +1 more source

Ravulizumab in pregnancy: the case for cautious optimism. [PDF]

Blood Adv
Shammo JM.
europepmc   +1 more source

Long-Term Therapy with Eculizumab Biosimilar in Patients with Atypical Haemolytic Uraemic Syndrome: Outcomes of a Prospective Observational Study.

Nephron
Kotenko O, Kozlovskaya N, Emirova K, Muzurov A, Moiseev S, Konakova I, Shavkin A, Makarova T, Gazizulina M, Vinogradov V, Ivanova E, Demyanova K, Korotchaeva Y, Proshina T, Melnikova Y, Рoladova L, Mazur Y, Markova O, Borozinets A.   +18 more
europepmc   +1 more source

Complement C5 inhibition in generalized myasthenia gravis is associated with improved survival and increased cardiovascular risk. [PDF]

Front Immunol
Vahldieck C, Fels B.
europepmc   +1 more source

Evaluating the treatment of patients with paroxysmal nocturnal hemoglobinuria in Brazil: disparities in access and treatment persistence. [PDF]

Hematol Transfus Cell Ther
Cançado RD, de Melo Campos P, Kashiura D, Thies F, Ferreira E, de Almeida ABM, Leonel LP, Cortez LV, Melo N, Fedozzi F, Bigoni A.   +10 more
europepmc   +1 more source

Clinical Spectrum and Differential Diagnosis of Adult Thrombotic Microangiopathies: Real-World Experience from a Tertiary Referral Center. [PDF]

Hematol Rep
Kırkayak NP, Ozet G, Dagdas S, Ceran F, Ates I.   +4 more
europepmc   +1 more source

Treatment of antibody-mediated rejection in heart transplantation: from empirical combination to multi-target precision intervention. [PDF]

Front Immunol
Xu N, Dong Y, Yue Y, Zhou L.
europepmc   +1 more source

Complement-targeted therapies for C3 glomerulopathy and atypical hemolytic uremic syndrome: a time-limited rapid systematic review with narrative synthesis. [PDF]

Front Med (Lausanne)
Wu Q, Yu Z, Wu Z, Yang L, Lin X.
europepmc   +1 more source

Complement C5 inhibitors as add-on rescue treatment in severe AQP4-antibody neuromyelitis optica spectrum disorder attacks: a case series and literature review. [PDF]

Ther Adv Neurol Disord
Gan KX, Abu Hassan SHB, Tan XL, Li KZ, Thirugnanam U, Yeo T.   +5 more
europepmc   +1 more source

Complement-targeted therapies for transplant-associated thrombotic microangiopathy: recent advances. [PDF]

Front Pharmacol
Tokura T, Motomura S.
europepmc   +1 more source